174 related articles for article (PubMed ID: 23641068)
1. Antagonism and synergy between extracellular BMP modulators Tsg and BMPER balance blood vessel formation.
Heinke J; Juschkat M; Charlet A; Mnich L; Helbing T; Bode C; Patterson C; Moser M
J Cell Sci; 2013 Jul; 126(Pt 14):3082-94. PubMed ID: 23641068
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor signaling pathway in endothelial cells is activated by BMPER to promote angiogenesis.
Esser JS; Rahner S; Deckler M; Bode C; Patterson C; Moser M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):358-67. PubMed ID: 25503991
[TBL] [Abstract][Full Text] [Related]
3. BMPER is an endothelial cell regulator and controls bone morphogenetic protein-4-dependent angiogenesis.
Heinke J; Wehofsits L; Zhou Q; Zoeller C; Baar KM; Helbing T; Laib A; Augustin H; Bode C; Patterson C; Moser M
Circ Res; 2008 Oct; 103(8):804-12. PubMed ID: 18787191
[TBL] [Abstract][Full Text] [Related]
4. BMPER Enhances Bone Formation by Promoting the Osteogenesis-Angiogenesis Coupling Process in Mesenchymal Stem Cells.
Xiao F; Wang C; Wang C; Gao Y; Zhang X; Chen X
Cell Physiol Biochem; 2018; 45(5):1927-1939. PubMed ID: 29518774
[TBL] [Abstract][Full Text] [Related]
5. Extracellular bone morphogenetic protein modulator BMPER and twisted gastrulation homolog 1 preserve arterial-venous specification in zebrafish blood vessel development and regulate Notch signaling in endothelial cells.
Esser JS; Steiner RE; Deckler M; Schmitt H; Engert B; Link S; Charlet A; Patterson C; Bode C; Zhou Q; Moser M
FEBS J; 2018 Apr; 285(8):1419-1436. PubMed ID: 29473997
[TBL] [Abstract][Full Text] [Related]
6. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
[TBL] [Abstract][Full Text] [Related]
7. Visfatin activates eNOS via Akt and MAP kinases and improves endothelial cell function and angiogenesis in vitro and in vivo: translational implications for atherosclerosis.
Lovren F; Pan Y; Shukla PC; Quan A; Teoh H; Szmitko PE; Peterson MD; Gupta M; Al-Omran M; Verma S
Am J Physiol Endocrinol Metab; 2009 Jun; 296(6):E1440-9. PubMed ID: 19351806
[TBL] [Abstract][Full Text] [Related]
8. Internal cleavage and synergy with twisted gastrulation enhance BMP inhibition by BMPER.
Lockhart-Cairns MP; Lim KTW; Zuk A; Godwin ARF; Cain SA; Sengle G; Baldock C
Matrix Biol; 2019 Apr; 77():73-86. PubMed ID: 30125619
[TBL] [Abstract][Full Text] [Related]
9. ERK signaling is a central regulator for BMP-4 dependent capillary sprouting.
Zhou Q; Heinke J; Vargas A; Winnik S; Krauss T; Bode C; Patterson C; Moser M
Cardiovasc Res; 2007 Dec; 76(3):390-9. PubMed ID: 17850776
[TBL] [Abstract][Full Text] [Related]
10. Bone morphogenetic protein endothelial cell precursor-derived regulator regulates retinal angiogenesis in vivo in a mouse model of oxygen-induced retinopathy.
Moreno-Miralles I; Ren R; Moser M; Hartnett ME; Patterson C
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2216-22. PubMed ID: 21737784
[TBL] [Abstract][Full Text] [Related]
11. Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function.
Helbing T; Wiltgen G; Hornstein A; Brauers EZ; Arnold L; Bauer A; Esser JS; Diehl P; Grundmann S; Fink K; Patterson C; Bode C; Moser M
Inflammation; 2017 Apr; 40(2):442-453. PubMed ID: 27995357
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein 4 regulates microRNAs miR-494 and miR-126-5p in control of endothelial cell function in angiogenesis.
Esser JS; Saretzki E; Pankratz F; Engert B; Grundmann S; Bode C; Moser M; Zhou Q
Thromb Haemost; 2017 Apr; 117(4):734-749. PubMed ID: 28124060
[TBL] [Abstract][Full Text] [Related]
13. Homologues of Twisted gastrulation are extracellular cofactors in antagonism of BMP signalling.
Scott IC; Blitz IL; Pappano WN; Maas SA; Cho KW; Greenspan DS
Nature; 2001 Mar; 410(6827):475-8. PubMed ID: 11260715
[TBL] [Abstract][Full Text] [Related]
14. Intermedin: a novel regulator for vascular remodeling and tumor vessel normalization by regulating vascular endothelial-cadherin and extracellular signal-regulated kinase.
Zhang W; Wang LJ; Xiao F; Wei Y; Ke W; Xin HB
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2721-32. PubMed ID: 22922959
[TBL] [Abstract][Full Text] [Related]
15. LRP1-dependent endocytic mechanism governs the signaling output of the bmp system in endothelial cells and in angiogenesis.
Pi X; Schmitt CE; Xie L; Portbury AL; Wu Y; Lockyer P; Dyer LA; Moser M; Bu G; Flynn EJ; Jin SW; Patterson C
Circ Res; 2012 Aug; 111(5):564-74. PubMed ID: 22777006
[TBL] [Abstract][Full Text] [Related]
16. DICAM inhibits angiogenesis via suppression of AKT and p38 MAP kinase signalling.
Han SW; Jung YK; Lee EJ; Park HR; Kim GW; Jeong JH; Han MS; Choi JY
Cardiovasc Res; 2013 Apr; 98(1):73-82. PubMed ID: 23386276
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
Huang SW; Lien JC; Kuo SC; Huang TF
Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
[TBL] [Abstract][Full Text] [Related]
18. Twisted gastrulation is a conserved extracellular BMP antagonist.
Ross JJ; Shimmi O; Vilmos P; Petryk A; Kim H; Gaudenz K; Hermanson S; Ekker SC; O'Connor MB; Marsh JL
Nature; 2001 Mar; 410(6827):479-83. PubMed ID: 11260716
[TBL] [Abstract][Full Text] [Related]
19. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
20. Twisted gastrulation, a bone morphogenetic protein agonist/antagonist, is not required for post-natal skeletal function.
Gazzerro E; Deregowski V; Stadmeyer L; Gale NW; Economides AN; Canalis E
Bone; 2006 Dec; 39(6):1252-60. PubMed ID: 16934545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
